These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 9503276)

  • 1. Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis.
    Rudolf J; Grond M; Neveling M; Heiss WD
    J Neural Transm (Vienna); 1997; 104(11-12):1305-11. PubMed ID: 9503276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine for the treatment of psychosis in Parkinson's disease: a review.
    Auzou P; Ozsancak C; Hannequin D; Moore N; Augustin P
    Acta Neurol Scand; 1996 Nov; 94(5):329-36. PubMed ID: 8947285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M; Courtet P; Castelnau D
    Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine prevents recurrence of psychosis in Parkinson's disease.
    Factor SA; Brown D
    Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I; Bezchlibnyk-Butler K; Wong L
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
    Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
    Kolli V; Denton K; Borra D; Pulluri M; Sharma A
    Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine for drug-induced psychosis in Parkinson's disease.
    Brown TM
    N Engl J Med; 1999 Aug; 341(6):456. PubMed ID: 10438274
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
    Factor SA; Molho ES; Brown DL
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
    van de Loosdrecht AA; Faber HJ; Hordijk P; Uges DR; Smit A
    Neth J Med; 1998 Jan; 52(1):26-9. PubMed ID: 9573739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of clozapine in Brazilian patients with Parkinson's disease.
    Gomide L; Kummer A; Cardoso F; Teixeira AL
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):611-4. PubMed ID: 18949249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
    Raveendranathan D; Sharma E; Venkatasubramanian G; Rao MG; Varambally S; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(5):574.e5-6. PubMed ID: 22902258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 15. Clozapine in the treatment of psychosis in Parkinson's disease.
    Friedman JH; Lannon MC
    Neurology; 1989 Sep; 39(9):1219-21. PubMed ID: 2771073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing psychosis in patients with Parkinson's disease.
    Cummings JL
    N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
    [No Abstract]   [Full Text] [Related]  

  • 17. Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
    Ruggieri S; De Pandis MF; Bonamartini A; Vacca L; Stocchi F
    Clin Neuropharmacol; 1997 Jun; 20(3):204-9. PubMed ID: 9197942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P; Slater S; Measham T; Koch M; Wiviott G
    Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
    Bauer M; Mackert A
    J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.